ADALIMUMAB-AFZB for Crohn's disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 913 adverse event reports in the FDA FAERS database where ADALIMUMAB-AFZB was used for Crohn's disease.
Most Reported Side Effects for ADALIMUMAB-AFZB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 748 | 35.8% | 30 | 129 |
| Condition aggravated | 533 | 25.5% | 9 | 107 |
| Drug ineffective | 254 | 12.2% | 7 | 46 |
| Fatigue | 231 | 11.1% | 8 | 50 |
| Arthralgia | 190 | 9.1% | 2 | 32 |
| Pain | 170 | 8.1% | 7 | 30 |
| Injection site pain | 159 | 7.6% | 0 | 13 |
| Drug dose omission by device | 116 | 5.6% | 1 | 9 |
| Nausea | 115 | 5.5% | 3 | 20 |
| Headache | 113 | 5.4% | 1 | 27 |
| Inappropriate schedule of product administration | 110 | 5.3% | 3 | 28 |
| Malaise | 109 | 5.2% | 5 | 31 |
| Abdominal pain | 107 | 5.1% | 2 | 32 |
| Diarrhoea | 102 | 4.9% | 2 | 27 |
| Therapeutic product effect incomplete | 93 | 4.5% | 1 | 21 |
Other Indications for ADALIMUMAB-AFZB
Rheumatoid arthritis (337)
Hidradenitis (190)
Colitis ulcerative (166)
Ankylosing spondylitis (153)
Psoriatic arthropathy (146)
Uveitis (41)
Juvenile idiopathic arthritis (38)
Psoriasis (37)
Product used for unknown indication (18)
Other Drugs Used for Crohn's disease
ADALIMUMAB (99,540)
INFLIXIMAB (40,796)
VEDOLIZUMAB (28,718)
USTEKINUMAB (22,537)
RISANKIZUMAB-RZAA (12,561)
INFLIXIMAB-DYYB (10,657)
HUMIRA (10,174)
CERTOLIZUMAB PEGOL (8,758)
UPADACITINIB (4,390)
MESALAMINE (2,930)